Literature DB >> 23600958

Pyranoflavones: a group of small-molecule probes for exploring the active site cavities of cytochrome P450 enzymes 1A1, 1A2, and 1B1.

Jiawang Liu1, Shannon F Taylor, Patrick S Dupart, Corey L Arnold, Jayalakshmi Sridhar, Quan Jiang, Yuji Wang, Elena V Skripnikova, Ming Zhao, Maryam Foroozesh.   

Abstract

Selective inhibition of P450 enzymes is the key to block the conversion of environmental procarcinogens to their carcinogenic metabolites in both animals and humans. To discover highly potent and selective inhibitors of P450s 1A1, 1A2, and 1B1, as well as to investigate active site cavities of these enzymes, 14 novel flavone derivatives were prepared as chemical probes. Fluorimetric enzyme inhibition assays were used to determine the inhibitory activities of these probes toward P450s 1A1, 1A2, 1B1, 2A6, and 2B1. A highly selective P450 1B1 inhibitor 5-hydroxy-4'-propargyloxyflavone (5H4'FPE) was discovered. Some tested compounds also showed selectivity between P450s 1A1 and 1A2. α-Naphthoflavone-like and 5-hydroxyflavone derivatives preferentially inhibited P450 1A2, while β-naphthoflavone-like flavone derivatives showed selective inhibition of P450 1A1. On the basis of structural analysis, the active site cavity models of P450 enzymes 1A1 and 1A2 were generated, demonstrating a planar long strip cavity and a planar triangular cavity, respectively.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23600958      PMCID: PMC3685175          DOI: 10.1021/jm4003654

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  32 in total

1.  Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.

Authors:  Vasilis P Androutsopoulos; Athanasios Papakyriakou; Dionisios Vourloumis; Demetrios A Spandidos
Journal:  Bioorg Med Chem       Date:  2011-03-24       Impact factor: 3.641

2.  Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice humanized for CYP1A1 and CYP1A2.

Authors:  Connie Cheung; Xiaochao Ma; Kristopher W Krausz; Shioko Kimura; Lionel Feigenbaum; Timothy P Dalton; Daniel W Nebert; Jeffrey R Idle; Frank J Gonzalez
Journal:  Chem Res Toxicol       Date:  2005-09       Impact factor: 3.739

3.  p53 Mutagenesis by benzo[a]pyrene derived radical cations.

Authors:  Sushmita Sen; Pratik Bhojnagarwala; Lauren Francey; Ding Lu; Trevor M Penning; Jeffrey Field
Journal:  Chem Res Toxicol       Date:  2012-08-09       Impact factor: 3.739

4.  Different mechanisms for inhibition of human cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic inhibitors.

Authors:  Tsutomu Shimada; Norie Murayama; Kazushi Okada; Yoshihiko Funae; Hiroshi Yamazaki; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2007-02-10       Impact factor: 3.739

5.  Regioselectivity in aromatic Claisen rearrangements.

Authors:  Fábio Cesar Gozzo; Sergio Antonio Fernandes; Denise Cristina Rodrigues; Marcos Nogueira Eberlin; Anita Jocelyne Marsaioli
Journal:  J Org Chem       Date:  2003-07-11       Impact factor: 4.354

6.  Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver.

Authors:  M D Burke; S Thompson; R J Weaver; C R Wolf; R T Mayer
Journal:  Biochem Pharmacol       Date:  1994-08-30       Impact factor: 5.858

Review 7.  Insights into the structure, function, and regulation of human cytochrome P450 1A2.

Authors:  Shu-Feng Zhou; Eli Chan; Zhi-Wei Zhou; Charlie Changli Xue; Xinsheng Lai; Wei Duan
Journal:  Curr Drug Metab       Date:  2009-09       Impact factor: 3.731

8.  Genotoxic activation of the environmental pollutant 3,6-dinitrobenzo[e]pyrene in Salmonella typhimurium umu strains expressing human cytochrome P450 and N-acetyltransferase.

Authors:  Yoshimitsu Oda; Teruhisa Hirayama; Tetsushi Watanabe
Journal:  Toxicol Lett       Date:  2009-04-23       Impact factor: 4.372

9.  A highly sensitive tool for the assay of cytochrome P450 enzyme activity in rat, dog and man. Direct fluorescence monitoring of the deethylation of 7-ethoxy-4-trifluoromethylcoumarin.

Authors:  J T Buters; C D Schiller; R C Chou
Journal:  Biochem Pharmacol       Date:  1993-11-02       Impact factor: 5.858

Review 10.  Cytochrome p450 and chemical toxicology.

Authors:  F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2007-12-06       Impact factor: 3.739

View more
  9 in total

1.  Combinatorial Synthesis of Structurally Diverse Triazole-Bridged Flavonoid Dimers and Trimers.

Authors:  Tze Han Sum; Tze Jing Sum; Warren R J D Galloway; Súil Collins; David G Twigg; Florian Hollfelder; David R Spring
Journal:  Molecules       Date:  2016-09-16       Impact factor: 4.411

Review 2.  Potential role of CYP1B1 in the development and treatment of metabolic diseases.

Authors:  Fei Li; Weifeng Zhu; Frank J Gonzalez
Journal:  Pharmacol Ther       Date:  2017-03-16       Impact factor: 12.310

3.  A Ligand-Based Drug Design. Discovery of 4-Trifluoromethyl-7,8-pyranocoumarin as a Selective Inhibitor of Human Cytochrome P450 1A2.

Authors:  Jiawang Liu; Peter T Pham; Elena V Skripnikova; Shilong Zheng; La'nese J Lovings; Yuji Wang; Navneet Goyal; Sydni M Bellow; Lydia M Mensah; Amari J Chatters; Melyssa R Bratton; Thomas E Wiese; Ming Zhao; Guangdi Wang; Maryam Foroozesh
Journal:  J Med Chem       Date:  2015-08-10       Impact factor: 7.446

4.  Human Cytochrome P450 1A1 Adapts Active Site for Atypical Nonplanar Substrate.

Authors:  Aaron G Bart; Ryan H Takahashi; Xiaojing Wang; Emily E Scott
Journal:  Drug Metab Dispos       Date:  2019-11-22       Impact factor: 3.922

Review 5.  Review of Ligand Specificity Factors for CYP1A Subfamily Enzymes from Molecular Modeling Studies Reported to-Date.

Authors:  Jayalakshmi Sridhar; Navneet Goyal; Jiawang Liu; Maryam Foroozesh
Journal:  Molecules       Date:  2017-07-08       Impact factor: 4.411

6.  Identification of CYP 2A6 inhibitors in an effort to mitigate the harmful effects of the phytochemical nicotine.

Authors:  Navneet Goyal; Jayalakshmi Sridhar; Camilla Do; Melyssa Bratton; Shahensha Shaik; Quan Jiang; Maryam Foroozesh
Journal:  J Cancer Metastasis Treat       Date:  2021-04-14

7.  Ethynylflavones, highly potent, and selective inhibitors of cytochrome P450 1A1.

Authors:  Navneet Goyal; Jiawang Liu; La'Nese Lovings; Patrick Dupart; Shannon Taylor; Sydni Bellow; Lydia Mensah; Erika McClain; Brandan Dotson; Jayalakshmi Sridhar; Xiaoyi Zhang; Ming Zhao; Maryam Foroozesh
Journal:  Chem Res Toxicol       Date:  2014-07-29       Impact factor: 3.739

Review 8.  Cytochrome P450 family 1 inhibitors and structure-activity relationships.

Authors:  Jiawang Liu; Jayalakshmi Sridhar; Maryam Foroozesh
Journal:  Molecules       Date:  2013-11-25       Impact factor: 4.411

Review 9.  Structure-Based Drug Design for Cytochrome P450 Family 1 Inhibitors.

Authors:  Zbigniew Dutkiewicz; Renata Mikstacka
Journal:  Bioinorg Chem Appl       Date:  2018-07-25       Impact factor: 7.778

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.